ABBV AbbVie Inc.
Healthcare$213.09-1.21%ClosedMarket Cap: $376.49B
As of 2026-05-26
Valuation
P/E (TTM)
87.05
PEG
—
P/B
13.91
P/S
6.07
EV/EBITDA
26.27
DCF Value
$137.87
FCF Yield
5.5%
Div Yield
3.1%
Margins & Returns
Gross Margin
70.7%
Operating Margin
27.6%
Net Margin
5.8%
ROE
68.0%
ROA
2.7%
ROIC
10.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $15.00B | 71.9% | $4.73B | $699.0M | $— | $1.73 |
| Q4 null | $16.62B | 72.6% | $5.81B | $1.82B | $— | $1.64 |
| FY null | $61.16B | 70.2% | $20.09B | $4.23B | $— | $6.56 |
| Q3 null | $15.78B | 66.4% | $1.90B | $186.0M | $— | $1.64 |
| Q2 null | $15.42B | 71.8% | $4.89B | $938.0M | $— | $1.64 |
| Q1 null | $13.34B | 70.0% | $3.73B | $1.29B | $— | $1.64 |
| Q4 null | $15.10B | 70.9% | $-1.49B | $-22.0M | $— | $1.55 |
| FY null | $56.33B | 70.0% | $9.14B | $4.28B | $— | $6.20 |
| Q3 null | $14.46B | 70.9% | $3.83B | $1.56B | $— | $1.55 |
| Q2 null | $14.46B | 70.9% | $4.00B | $1.37B | $— | $1.55 |
| Q1 null | $12.31B | 66.7% | $2.80B | $1.37B | $— | $1.55 |
| Q4 2023 | $14.30B | 60.1% | $3.19B | $822.0M | $0.46 | $1.48 |